A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric Siemers, MD
Acumen Pharmaceuticals, Inc.
Principal Investigator - Russell Barton
Acumen Pharmaceuticals, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinical Endpoints
Scottsdale, Arizona, United States
- Orange County Research Institute
Anaheim, California, United States
- Hoag Hospital Newport Beach
Newport Beach, California, United States
- Velocity Clinical Research
Hallandale, Florida, United States
- Charter Research
Lady Lake, Florida, United States
- Columbus Clinical Services
Miami, Florida, United States
- Combined Research Orlando Phase I-Iv
Orlando, Florida, United States
- Progressive Medical Research
Port Orange, Florida, United States
- Santos Research Center
Tampa, Florida, United States
- Atlanta Center for Medical Research
Atlanta, Georgia, United States
- Iresearch Atlanta
Decatur, Georgia, United States
- Advanced Memory Research Institute of Nj
Toms River, New Jersey, United States
- Columbia University
New York, New York, United States
- Amc Research
Matthews, North Carolina, United States
- Abington Neurological Associates
Abington, Pennsylvania, United States
- Kerwin Medical Center
Dallas, Texas, United States
- Clinical Trials Network
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Jun 2021
- Primary completion
- 12 Jun 2023
- Completion
- 12 Jun 2023
- Last update posted
- 19 Jul 2023
- Registered enrollment
- 65
- Registry id
- NCT04931459
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.